<DOC>
	<DOCNO>NCT00317850</DOCNO>
	<brief_summary>The specific aim Gabapentin Relief Idiopathic Subjective Tinnitus Trial ass therapeutic benefit Gabapentin ( NeurontinÂ® ) subjective idiopathic troublesome tinnitus . We employ double-blind placebo-controlled randomized clinical trial design ass efficacy Gabapentin . Adults , age 18 70 idiopathic , subjective , troublesome , unilateral bilateral , non-pulsatile tinnitus 6 month 's duration great score 38 great Tinnitus Handicap Inventory enrol .</brief_summary>
	<brief_title>Gabapentin Treatment Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Adults , age 18 70 Idiopathic , subjective , troublesome , unilateral bilateral , nonpulsatile tinnitus ( ICD9 388.31 ) 6 month 's duration great Tinnitus handicap score 38 great Tinnitus Handicap Inventory . The symptom tinnitus affect concomitant use tricyclic antidepressant , carbamazepine , phenytoin , valproate sodium , benzodiazepine . Patients use drug within 30 day screen enrolled . Impaired renal function determine serum creatinine level , use follow formulas35 : adult male Ccr = ( 140 age ) X weight kilograms/ ( 72 X serum creatinine milligram per deciliter ) ; adult female Ccr = [ ( 140 age ) X weight kilograms/ ( 72 X serum creatinine milligram per deciliter ) ] X 0.85 , whereCcr indicate creatinine clearance . Patients tinnitus related cochlear implantation , retrocochlear lesion , know anatomic/structural lesion ear temporal bone Patients serious unstable medical psychiatric condition . Patients whose ability give inform consent question .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>